Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Buchanan

Showing results (71-80 of 298) with videos related to

Pageof 30
Sort By:
Familial Cancer|December 19, 2015
Determining the familial risk distribution of colorectal cancer: a data mining approachRowena Chau, Mark A Jenkins, Daniel D Buchanan, et al.
Clinical Epigenetics|July 10, 2020
The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instabilityHolly Russell, Katarzyna Kedzierska, Daniel D Buchanan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family RegistryA Joan Levine, Aung Ko Win, Daniel D Buchanan, et al.
Journal of the National Cancer Institute|August 13, 2014
Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognosticationChristophe Rosty, Elizabeth J Williamson, Mark Clendenning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patientsMichael D Walsh, Margaret C Cummings, Daniel D Buchanan, et al.
Clinical Epigenetics|April 2, 2021
Correction to: The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instabilityHolly Russell, Katarzyna Kedzierska, Daniel D Buchanan, et al.
Gut|March 26, 2018
Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort StudyJihoon E Joo, Harindra Jayasekara, Ee Ming Wong, et al.
European Journal of Human Genetics : EJHG|November 30, 2006
Stability of BAT26 in Lynch syndrome colorectal tumoursLesley Jaskowski, Joanne Young, Leigh Jackson, et al.
Molecular Carcinogenesis|December 5, 2013
Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicityMichael T Parsons, Phillip J Whiley, Jonathan Beesley, et al.
Familial Cancer|June 3, 2017
RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancersLochlan J Fennell, Mark Clendenning, Diane M McKeone, et al.
Pageof 30

Showing results (71-80 of 298) with videos related to

Sort By:
Pageof 30
Familial Cancer|December 19, 2015
Determining the familial risk distribution of colorectal cancer: a data mining approachRowena Chau, Mark A Jenkins, Daniel D Buchanan, et al.
Clinical Epigenetics|July 10, 2020
The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instabilityHolly Russell, Katarzyna Kedzierska, Daniel D Buchanan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family RegistryA Joan Levine, Aung Ko Win, Daniel D Buchanan, et al.
Journal of the National Cancer Institute|August 13, 2014
Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognosticationChristophe Rosty, Elizabeth J Williamson, Mark Clendenning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patientsMichael D Walsh, Margaret C Cummings, Daniel D Buchanan, et al.
Clinical Epigenetics|April 2, 2021
Correction to: The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instabilityHolly Russell, Katarzyna Kedzierska, Daniel D Buchanan, et al.
Gut|March 26, 2018
Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort StudyJihoon E Joo, Harindra Jayasekara, Ee Ming Wong, et al.
European Journal of Human Genetics : EJHG|November 30, 2006
Stability of BAT26 in Lynch syndrome colorectal tumoursLesley Jaskowski, Joanne Young, Leigh Jackson, et al.
Molecular Carcinogenesis|December 5, 2013
Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicityMichael T Parsons, Phillip J Whiley, Jonathan Beesley, et al.
Familial Cancer|June 3, 2017
RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancersLochlan J Fennell, Mark Clendenning, Diane M McKeone, et al.
Pageof 30